Tolfenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) primarily used for its analgesic and anti-inflammatory properties. Commonly available under trade names like Clotam and Tolfedine, it has been a subject of interest in various research circles, including institutions focused on drug development and neurological studies. As an NSAID, Tolfenamic acid is used to treat a range of conditions, including
migraines and other
types of pain and
inflammation. Its potential applications are continuously being explored in preclinical and clinical settings, particularly in relation to its effects on
cancer cells and
neuroinflammatory conditions.
Tolfenamic acid works primarily through the inhibition of cyclooxygenase (COX) enzymes, specifically
COX-1 and
COX-2. These enzymes are critical in the biosynthesis of prostaglandins, which are lipid compounds that have several roles in the body, including the mediation of inflammation and pain. By inhibiting these enzymes, Tolfenamic acid effectively reduces the production of prostaglandins, thereby alleviating pain and inflammation. Additionally, some studies suggest that Tolfenamic acid may have a role in modulating certain pathways related to tumor growth and
neuroinflammation, making it a molecule of interest for broader therapeutic applications.
Tolfenamic acid is typically administered orally, although the dosage and frequency can vary based on the condition being treated. For
acute migraine attacks, a single dose is often sufficient, while chronic conditions might require a more regular dosing schedule. The drug is usually taken with food to minimize gastrointestinal discomfort. Upon administration, patients can expect the onset of relief within 30 minutes to an hour, making it a relatively fast-acting option for pain management. It's crucial for patients to follow their healthcare provider's dosing instructions carefully to maximize efficacy and minimize potential side effects.
Like all medications, Tolfenamic acid is associated with a range of potential side effects. Common adverse effects include gastrointestinal issues such as
nausea,
vomiting, and
stomach pain. More severe gastrointestinal complications, like
ulcers or
bleeding, can occur, especially with long-term use. Other notable side effects include
dizziness,
headache, and
allergic reactions such as
rash or
itching. Because of its blood-thinning properties, Tolfenamic acid can increase the risk of bleeding, particularly in individuals with
coagulation disorders or those taking other anticoagulant medications. It is contraindicated in patients with known hypersensitivity to NSAIDs,
active gastrointestinal ulcers, and severe
renal or hepatic impairment. Pregnant or breastfeeding women should avoid using the drug unless specifically advised by their healthcare provider.
Several other drugs can interact with Tolfenamic acid, potentially altering its effectiveness or increasing the risk of adverse effects. Concomitant use with other NSAIDs or corticosteroids can heighten the risk of gastrointestinal side effects. Blood thinners like
warfarin and antiplatelet agents such as
aspirin can exacerbate bleeding risks when taken alongside Tolfenamic acid. Additionally, medications that impact renal function, such as certain diuretics and
ACE inhibitors, may increase the risk of kidney damage when used in conjunction with this drug. Patients should always inform their healthcare providers of all medications they are currently taking, including over-the-counter drugs and supplements, to ensure safe and effective use of Tolfenamic acid.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


